We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Tyratech (DI/S) | LSE:TYR | London | Ordinary Share | COM SHS USD0.001 (DI / REGS) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 2.95 | 2.70 | 3.20 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMTYR TIDMTYRU
RNS Number : 3052G
TyraTech, Inc.
03 March 2015
TyraTech, Inc.
("TyraTech" or the "Company")
Vamousse(R) head lice products now listed by top three distributors
in the USA
TyraTech, Inc. (AIM: TYR and TYRU), a life sciences company focused on nature-derived insect and parasite control products, is pleased to announce that its Vamousse head lice products are now listed by AmerisourceBergen, the second biggest distributor of pharmaceutical products in the USA, further paving the way for distribution to the large network of independent pharmacies in the USA.
This agreement follows the recently announced listings for Vamousse obtained with McKesson and Cardinal Health, the number one and number three distributors of pharmaceutical products in the USA respectively.
These listings represent an important milestone for Tyratech providing the essential first step in accessing the approximate 20,000 independent pharmacies in the USA. With combined estimated sales of more than $350 billion in 2014, these three distributors have specific programs designed to reach independent pharmacies and chains of local and regional pharmacies. The listings will now allow TyraTech to access these specific programs and progressively deploy its Vamousse products during 2015 and beyond.
Bruno Jactel, Chief Executive Officer, said: "This new listing with AmerisourceBergen marks another important step in the commercialisation of our core intellectual property and in the expansion of our distribution network for our Vamousse products. Following the recent listing of Vamousse Protection Shampoo at Walmart and the addition of Lloyds and Day Lewis in the UK, we are delighted to have added the three biggest distributors to independent pharmacies in the USA, giving us an important route into the 20,000 independent pharmacies in the USA. The team at TyraTech is very excited by the growth opportunities presented by the continually expanding distribution network for Vamousse products."
Further information on Vamousse(TM) is available on the Company's website at http://www.vamousselice.com/
TyraTech Inc. Bruno Jactel, Chief Executive Tel: +1 919 Officer 415 4340 Vince Morgus, Chief Financial Tel: +1 919 Officer & Treasurer 415 4287 --------------------------------- -------------- SPARK Advisory Partners Limited, Tel: +44203 Nominated Adviser 368 3552 Matt Davis / Mark Brady Tel: +44203 368 3551 --------------------------------- -------------- Allenby Capital Limited , Joint Broker Tel: +44 20 Chris Crawford 3328 5656 --------------------------------- -------------- Whitman Howard Limited, Joint Broker Tel: +44 20 Ranald Mc-Gregor Smith / 7659 1240 Niall Devins --------------------------------- -------------- Walbrook, Financial PR and IR Tel: +44 20 Nick Rome /Guy McDougall 7933 8790 --------------------------------- --------------
This information is provided by RNS
The company news service from the London Stock Exchange
END
MSCLLFLDVIIFIIE
1 Year Tyratech Chart |
1 Month Tyratech Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions